PK
Pankaj Kumar
Also known as: Structural Biologist and Biophysical Chemist
CytomX Therapeutics (United States), Johns Hopkins University, Institute of Microbial Technology CSIR, Jamia Hamdard
Employment
-
CytomX Therapeutics (United States) Senior Scientist-II2022 - Present
-
Johns Hopkins University Research Associate Faculty2021 - Present
-
Jamia Hamdard Assistant Professor2018 - 2021
-
Johns Hopkins University Senior Fellow2011 - 2018
-
Howard Hughes Medical Institute Research Associate2011 - 2013
Education
-
Institute of Microbial Technology CSIR PhD2005 - 2010
Projects & Funding
Projects & funding information is unavailable.
Publications (18)
- Allosteric cooperation in β-lactam binding to a non-classical transpeptidase Save
- Non-Synonymous Mutation Analysis in SARS-CoV-2 Variants Isolated from Humans and Prediction of Conserved Linear Antibody Epitopes for Use in Country-wise Epitope-Based Vaccine Development Save
- A nucleotide-dependent oligomerization of the Escherichia coli replication initiator DnaA requires residue His136 for remodeling of the chromosomal origin Save
- Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy Save
- Second-generation IL-2 receptor-targeted diphtheria fusion toxin exhibits antitumor activity and synergy with anti–PD-1 in melanoma Save
- Repurposing of Carbapenems for the Treatment of Drug-Resistant Tuberculosis Save
- Inhibition of innate immune cytosolic surveillance by an M. tuberculosis phosphodiesterase. Save
- Non-classical transpeptidases yield insight into new antibacterials. Save
- Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis. Save
- Structural insight into the inactivation of Mycobacterium tuberculosis non-classical transpeptidase LdtMt2 by biapenem and tebipenem. Save